Osimertinib
Osimertinib market is segmented by region (country), players, by Type and by Application. Players ... Read More
Global and United States Neratinib Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Neratinib Product Introduction
1.2 Global Neratinib Outlook 2017 VS 2022 VS 2028
1.2.1 Global Neratinib Sales in US$ Million for the Year 2017-2028
1.2.2 Global Neratinib Sales in Volume for the Year 2017-2028
1.3 United States Neratinib Outlook 2017 VS 2022 VS 2028
1.3.1 United States Neratinib Sales in US$ Million for the Year 2017-2028
1.3.2 United States Neratinib Sales in Volume for the Year 2017-2028
1.4 Neratinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Neratinib in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Neratinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Neratinib Market Dynamics
1.5.1 Neratinib Industry Trends
1.5.2 Neratinib Market Drivers
1.5.3 Neratinib Market Challenges
1.5.4 Neratinib Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Neratinib Market Segment by Type
2.1.1 40mg/180 Tablets
2.1.2 40mg/150 Tablets
2.1.3 40mg/90 Tablets
2.2 Global Neratinib Market Size by Type
2.2.1 Global Neratinib Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Neratinib Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Neratinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Neratinib Market Size by Type
2.3.1 United States Neratinib Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Neratinib Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Neratinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Neratinib Market Segment by Application
3.1.1 Early Breast Cancer
3.1.2 Other
3.2 Global Neratinib Market Size by Application
3.2.1 Global Neratinib Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Neratinib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Neratinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Neratinib Market Size by Application
3.3.1 United States Neratinib Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Neratinib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Neratinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Neratinib Competitor Landscape by Company
4.1 Global Neratinib Market Size by Company
4.1.1 Top Global Neratinib Manufacturers Ranked by Revenue (2021)
4.1.2 Global Neratinib Revenue by Manufacturer (2017-2022)
4.1.3 Global Neratinib Sales by Manufacturer (2017-2022)
4.1.4 Global Neratinib Price by Manufacturer (2017-2022)
4.2 Global Neratinib Concentration Ratio (CR)
4.2.1 Neratinib Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Neratinib in 2021
4.2.3 Global Neratinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Neratinib Manufacturing Base Distribution, Product Type
4.3.1 Global Neratinib Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Neratinib Product Type
4.3.3 Date of International Manufacturers Enter into Neratinib Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Neratinib Market Size by Company
4.5.1 Top Neratinib Players in United States, Ranked by Revenue (2021)
4.5.2 United States Neratinib Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Neratinib Sales by Players (2020, 2021 & 2022)
5 Global Neratinib Market Size by Region
5.1 Global Neratinib Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Neratinib Market Size in Volume by Region (2017-2028)
5.2.1 Global Neratinib Sales in Volume by Region: 2017-2022
5.2.2 Global Neratinib Sales in Volume Forecast by Region (2023-2028)
5.3 Global Neratinib Market Size in Value by Region (2017-2028)
5.3.1 Global Neratinib Sales in Value by Region: 2017-2022
5.3.2 Global Neratinib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Neratinib Market Size YoY Growth 2017-2028
6.1.2 North America Neratinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Neratinib Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Neratinib Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Neratinib Market Size YoY Growth 2017-2028
6.3.2 Europe Neratinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Neratinib Market Size YoY Growth 2017-2028
6.4.2 Latin America Neratinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Neratinib Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Neratinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Puma Biotechnology
7.1.1 Puma Biotechnology Corporation Information
7.1.2 Puma Biotechnology Description and Business Overview
7.1.3 Puma Biotechnology Neratinib Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Puma Biotechnology Neratinib Products Offered
7.1.5 Puma Biotechnology Recent Development
7.2 Beacon Pharmaceuticals Limited
7.2.1 Beacon Pharmaceuticals Limited Corporation Information
7.2.2 Beacon Pharmaceuticals Limited Description and Business Overview
7.2.3 Beacon Pharmaceuticals Limited Neratinib Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Beacon Pharmaceuticals Limited Neratinib Products Offered
7.2.5 Beacon Pharmaceuticals Limited Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Neratinib Industry Chain Analysis
8.2 Neratinib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Neratinib Distributors
8.3 Neratinib Production Mode & Process
8.4 Neratinib Sales and Marketing
8.4.1 Neratinib Sales Channels
8.4.2 Neratinib Distributors
8.5 Neratinib Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Neratinib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Neratinib Market Trends
Table 3. Neratinib Market Drivers
Table 4. Neratinib Market Challenges
Table 5. Neratinib Market Restraints
Table 6. Global Neratinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Neratinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Neratinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Neratinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Neratinib Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Neratinib Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Neratinib Revenue Share by Manufacturer, 2017-2022
Table 13. Global Neratinib Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Neratinib Sales Share by Manufacturer, 2017-2022
Table 15. Global Neratinib Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Neratinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Neratinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neratinib as of 2021)
Table 18. Top Players of Neratinib in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Neratinib Product Type
Table 20. Date of International Manufacturers Enter into Neratinib Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Neratinib Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Neratinib Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Neratinib Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Neratinib Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Neratinib Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Neratinib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Neratinib Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Neratinib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Neratinib Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Neratinib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Neratinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Neratinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Neratinib Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Neratinib Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Neratinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Neratinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Neratinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Neratinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Neratinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Neratinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Puma Biotechnology Corporation Information
Table 43. Puma Biotechnology Description and Business Overview
Table 44. Puma Biotechnology Neratinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Puma Biotechnology Neratinib Product
Table 46. Puma Biotechnology Recent Development
Table 47. Beacon Pharmaceuticals Limited Corporation Information
Table 48. Beacon Pharmaceuticals Limited Description and Business Overview
Table 49. Beacon Pharmaceuticals Limited Neratinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Beacon Pharmaceuticals Limited Product
Table 51. Beacon Pharmaceuticals Limited Recent Development
Table 52. Key Raw Materials Lists
Table 53. Raw Materials Key Suppliers Lists
Table 54. Neratinib Customers List
Table 55. Neratinib Distributors List
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Neratinib Product Picture
Figure 2. Global Neratinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Neratinib Market Size 2017-2028 (US$ Million)
Figure 4. Global Neratinib Sales 2017-2028 (K Pcs)
Figure 5. United States Neratinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Neratinib Market Size 2017-2028 (US$ Million)
Figure 7. United States Neratinib Sales 2017-2028 (K Pcs)
Figure 8. United States Neratinib Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Neratinib Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Neratinib Report Years Considered
Figure 11. Product Picture of 40mg/180 Tablets
Figure 12. Product Picture of 40mg/150 Tablets
Figure 13. Product Picture of 40mg/90 Tablets
Figure 14. Global Neratinib Market Share by Type in 2022 & 2028
Figure 15. Global Neratinib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Neratinib Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Neratinib Sales by Type (2017-2028) & (K Pcs)
Figure 18. Global Neratinib Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Neratinib Price by Type (2017-2028) & (USD/Pcs)
Figure 20. United States Neratinib Market Share by Type in 2022 & 2028
Figure 21. United States Neratinib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Neratinib Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Neratinib Sales by Type (2017-2028) & (K Pcs)
Figure 24. United States Neratinib Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Neratinib Price by Type (2017-2028) & (USD/Pcs)
Figure 26. Product Picture of Early Breast Cancer
Figure 27. Product Picture of Other
Figure 28. Global Neratinib Market Share by Application in 2022 & 2028
Figure 29. Global Neratinib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Neratinib Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Neratinib Sales by Application (2017-2028) & (K Pcs)
Figure 32. Global Neratinib Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Neratinib Price by Application (2017-2028) & (USD/Pcs)
Figure 34. United States Neratinib Market Share by Application in 2022 & 2028
Figure 35. United States Neratinib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Neratinib Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Neratinib Sales by Application (2017-2028) & (K Pcs)
Figure 38. United States Neratinib Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Neratinib Price by Application (2017-2028) & (USD/Pcs)
Figure 40. North America Neratinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 41. North America Neratinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Neratinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. Europe Neratinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Neratinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 52. Asia-Pacific Neratinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Neratinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 64. Latin America Neratinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Neratinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Middle East & Africa Neratinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Neratinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Neratinib Value Chain
Figure 74. Neratinib Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Puma Biotechnology Beacon Pharmaceuticals Limited